HD Biosciences Co., Ltd is a biology-focused preclinical drug discovery contract research organization (CRO), operating in Shanghai, China, San Diego, California, and Cranbury, New Jersey. Offering comprehensive service platforms in target validation, plate-based pharmacology, hit identification and lead discovery, in vivo pharmacology, and other R&D services, the company collaborates with global pharmaceutical and biotechnology firms. Established in 2004, it has earned a strong reputation for high-quality, consistent deliveries, and has garnered strategic partnerships with key impacts on client portfolio development. The last investment, a Series A round, was secured on 08 August 2008, with participation from Lilly Asia Ventures, Morningside Ventures, and Pfizer Venture Investments.
General Information
BounceWatch is an independent company data service, not affiliated with HD Biosciences Co., Ltd. To contact HD Biosciences Co., Ltd, visit hdbiosciences.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
China Market
Biotechnology
About HD Biosciences Co., Ltd
Taxonomy: Drug R&D, Preclinical Research, Contract Research Organization, Pharmaceuticals, Global Collaboration, Scientific Expertise, Target Validation, Hit Identification, Lead Discovery, In Vivo Pharmacology, Plate-based Pharmacology, Research and Development Services, Strategic Partnerships, Quality Deliveries
Funding Rounds & Investors (1)
View AllHD Biosciences Co., Ltd Alternatives & Competitors
View All AlternativesPreferred Research Partner for Preclinical Discovery
Capture the Untapped Value of Therapeutics
Translating innovative biology into bioactive molecules
FAQ About HD Biosciences Co., Ltd
Source: BounceWatch company record for HD Biosciences Co., Ltd, https://bouncewatch.com/company/hd-biosciences-co-ltd, updated 30 December 2024. When citing, please name BounceWatch and link this page.